Standard BioTools Management
Management criteria checks 0/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Key information
Michael Egholm
Chief executive officer
US$16.0m
Total compensation
| CEO salary percentage | 2.3% |
| CEO tenure | 2yrs |
| CEO ownership | 0.05% |
| Management average tenure | less than a year |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)
Mar 06
Standard BioTools Inc.'s (NASDAQ:LAB) P/S Still Appears To Be Reasonable
Feb 17Health Check: How Prudently Does Standard BioTools (NASDAQ:LAB) Use Debt?
Jan 12Is Standard BioTools (NASDAQ:LAB) A Risky Investment?
Aug 13Fluidigm Corporation: Investment Opportunity
Jan 26Does Fluidigm (NASDAQ:FLDM) Have A Healthy Balance Sheet?
Dec 15Is Fluidigm (NASDAQ:FLDM) A Risky Investment?
Jul 27Fluidigm Corporation: Discounted Life Sciences Instrument Developer Offers Compelling Entry Point
Jun 20Fluidigm gains after report that activist takes 11% stake, may push for unit sale
May 11Fluidigm Corporation 2021 Q1 - Results - Earnings Call Presentation
May 07Fluidigm Corporation (NASDAQ:FLDM) Analysts Just Slashed This Year's Estimates
Feb 15
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$75m |
| Sep 30 2023 | n/a | n/a | -US$76m |
| Jun 30 2023 | n/a | n/a | -US$84m |
| Mar 31 2023 | n/a | n/a | -US$131m |
| Dec 31 2022 | US$16m | US$373k | -US$190m |
Vergütung im Vergleich zum Markt: MichaelDie Gesamtvergütung ($USD16.02M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD3.30M).
Entschädigung vs. Einkommen: Unzureichende Daten, um die Vergütung von Michael mit der Unternehmensleistung zu vergleichen.
CEO
Michael Egholm (60 yo)
2yrs
Tenure
US$16,020,093
Compensation
Dr. Michael Egholm, Ph.D. served as the President of Biopharmaceuticals and Senior Vice President at Pall Corporation since July 2014 until January 17, 2017. He serves as Director at Abbratech, Inc. and Ab...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2yrs | US$16.02m | 0.054% $ 557.6k | |
| Chief Operating Officer | 2yrs | US$5.96m | 0.018% $ 189.5k | |
| Chief Financial Officer | less than a year | no data | 0.022% $ 232.1k | |
| Chief Technology Officer | less than a year | no data | no data | |
| Chief Strategy Officer | less than a year | no data | no data |
0.9yrs
Average Tenure
53yo
Average Age
Erfahrenes Management: LABDas Führungsteam des Unternehmens gilt nicht als erfahren ( 0 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2yrs | US$16.02m | 0.054% $ 557.6k | |
| Independent Director | 1.1yrs | no data | 0% $ 0 | |
| Independent Director | 2yrs | no data | 0.0091% $ 94.0k | |
| Director | less than a year | no data | no data | |
| Independent Director | 2yrs | US$274.00k | 0.027% $ 279.6k | |
| Chairman of the Board | less than a year | no data | no data | |
| Director | less than a year | no data | 0.023% $ 235.0k |
1.1yrs
Average Tenure
60.5yo
Average Age
Erfahrener Vorstand: LABDie Vorstandsmitglieder gelten nicht als erfahren ( 0 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.